Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?

Autoimmune pancreatitis (AIP) is a pancreatic manifestation of an IgG4-related disease (IgG4-RD). AIP lacks disease-specific biomarkers, and therefore, it is difficult to distinguish AIP from malignancies, especially pancreatic cancer. In this review, we have summarized the latest findings on potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokode, Masataka, Shiokawa, Masahiro, Kodama, Yuzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146865/
https://www.ncbi.nlm.nih.gov/pubmed/33923064
http://dx.doi.org/10.3390/diagnostics11050770
_version_ 1783697496282759168
author Yokode, Masataka
Shiokawa, Masahiro
Kodama, Yuzo
author_facet Yokode, Masataka
Shiokawa, Masahiro
Kodama, Yuzo
author_sort Yokode, Masataka
collection PubMed
description Autoimmune pancreatitis (AIP) is a pancreatic manifestation of an IgG4-related disease (IgG4-RD). AIP lacks disease-specific biomarkers, and therefore, it is difficult to distinguish AIP from malignancies, especially pancreatic cancer. In this review, we have summarized the latest findings on potential diagnostic biomarkers for AIP. Many investigations have been conducted, but no specific biomarkers for AIP are identified. Therefore, further studies are required to identify accurate diagnostic biomarkers for AIP.
format Online
Article
Text
id pubmed-8146865
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81468652021-05-26 Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now? Yokode, Masataka Shiokawa, Masahiro Kodama, Yuzo Diagnostics (Basel) Review Autoimmune pancreatitis (AIP) is a pancreatic manifestation of an IgG4-related disease (IgG4-RD). AIP lacks disease-specific biomarkers, and therefore, it is difficult to distinguish AIP from malignancies, especially pancreatic cancer. In this review, we have summarized the latest findings on potential diagnostic biomarkers for AIP. Many investigations have been conducted, but no specific biomarkers for AIP are identified. Therefore, further studies are required to identify accurate diagnostic biomarkers for AIP. MDPI 2021-04-25 /pmc/articles/PMC8146865/ /pubmed/33923064 http://dx.doi.org/10.3390/diagnostics11050770 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Yokode, Masataka
Shiokawa, Masahiro
Kodama, Yuzo
Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?
title Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?
title_full Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?
title_fullStr Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?
title_full_unstemmed Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?
title_short Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?
title_sort review of diagnostic biomarkers in autoimmune pancreatitis: where are we now?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146865/
https://www.ncbi.nlm.nih.gov/pubmed/33923064
http://dx.doi.org/10.3390/diagnostics11050770
work_keys_str_mv AT yokodemasataka reviewofdiagnosticbiomarkersinautoimmunepancreatitiswherearewenow
AT shiokawamasahiro reviewofdiagnosticbiomarkersinautoimmunepancreatitiswherearewenow
AT kodamayuzo reviewofdiagnosticbiomarkersinautoimmunepancreatitiswherearewenow

Ejemplares similares